Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Construction in Progress (2016 - 2025)

Icu Medical (ICUI) has disclosed Construction in Progress for 11 consecutive years, with $89.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Construction in Progress fell 19.18% year-over-year to $89.8 million, compared with a TTM value of $89.8 million through Sep 2025, down 19.18%, and an annual FY2024 reading of $87.0 million, down 25.77% over the prior year.
  • Construction in Progress was $89.8 million for Q3 2025 at Icu Medical, up from $88.7 million in the prior quarter.
  • Across five years, Construction in Progress topped out at $152.9 million in Q4 2022 and bottomed at $55.8 million in Q1 2021.
  • Average Construction in Progress over 5 years is $104.0 million, with a median of $106.1 million recorded in 2023.
  • The sharpest move saw Construction in Progress fell 28.04% in 2021, then surged 138.82% in 2022.
  • Year by year, Construction in Progress stood at $72.2 million in 2021, then soared by 111.92% to $152.9 million in 2022, then dropped by 23.34% to $117.2 million in 2023, then fell by 25.77% to $87.0 million in 2024, then rose by 3.18% to $89.8 million in 2025.
  • Business Quant data shows Construction in Progress for ICUI at $89.8 million in Q3 2025, $88.7 million in Q2 2025, and $84.8 million in Q1 2025.